MSN Laboratories Private Limited Montelukast Export Data — India (DGFT 2022–2026)

Name: MSN Laboratories Private Limited Montelukast Export Records India — #10 Exporter, 295 Shipments, $3.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Montelukast

India Pharmaceutical Trade Intelligence

$168.3M510 Suppliers138 CountriesHS 30049099

ExportsIndia → UNITED STATES58.1%India → PHILIPPINES7.9%

ImportsUNITED STATES → India$7.2K MALTA → India$6.9K

#1 Buyer: AMERISOURCE HEALTH

MSN Laboratories Private Limited — Montelukast Exporter #10 | $3.2M Trade Value | TransData Nexus | TransData Nexus

MSN Laboratories Private Limited — Montelukast Exporter Profile

Indian Pharmaceutical Exporter · #10 for Montelukast · $3.2M export value · DGFT Verified

MSN Laboratories Private Limited is the #10 Indian exporter of Montelukast with $3.2M in export value and 295 verified shipments. MSN Laboratories Private Limited holds a 1.9% market share in Montelukast exports across 18 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.

MSN Laboratories Private Limited — Montelukast Export Profile: Buyers & Destinations

MSN Laboratories Private Limited Montelukast export treemap — buyers and destination countries | TransData Nexus

Where Does MSN Laboratories Private Limited Export Montelukast?

Country	Value	Shipments	Share
JAMAICA	$1.1M	58	42.1%
MAURITIUS	$445.7K	27	17.3%
ZAMBIA	$157.1K	45	6.1%
FRANCE	$134.0K	19	5.2%
TANZANIA	$130.8K	29

Who Are the Top Buyers of Montelukast from MSN Laboratories Private Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	ZIMBABWE	$672.5K	82
TO THE ORDER OF.,	JAMAICA	$243.6K	16
SCOTT HEALTH LTD	MAURITIUS	$240.2K	11
LASCO DISTRIBUTORS LTD	JAMAICA	$214.3K	15
LASCO DISTRIBUTORS LTD,	JAMAICA	$150.0K	3
LASCO DISTRIBUTORS LTD ,	JAMAICA	$133.0K	8
LASCO DISTRIBUTORS LIMITED	JAMAICA	$117.6K	7
MEGA WECARE TANZANIA LIMITED	TANZANIA	$81.2K	11
SCOTT HEALTH LIMITED	MAURITIUS	$63.6K	3
KARIBU PHARMACEUTICALS LTD	ZAMBIA	$63.0K	14

MSN Laboratories Private Limited supplies Montelukast to 47 buyers globally. The largest buyer is TO THE ORDER OF (ZIMBABWE), followed by TO THE ORDER OF., (JAMAICA) and SCOTT HEALTH LTD (MAURITIUS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Montelukast Formulations Does MSN Laboratories Private Limited Export?

Product Description / Formulation	Value	Shipments
BREATHEZY L (MONTELUKAST+LEVOCITIRIZ 10+5) 3X10	$150.0K	3
MSN PHARMA- LEUTRIEN 10 (MONTELUKAST 10M	$86.6K	3
MSN LABS, BREATHEZY 10 (MONTELUKAST 10MG	$69.6K	4
Breathezy 10 Montelukast 10mg 3x10 BATCH NO BRF03077C	$67.3K	4
BREATHEZY 10 (MONTELUKAST 10MG) 3X10	$64.8K	5
BREATHEZY 10 (MONTELUKAST 10MG) 3X10NOS	$53.9K	2
BREATHEZY L (MONTELUKAST+LEVOCITIRIZ 10+	$52.1K	3
MSN PHARMACEUTICALS BREATHEZY L MONTELUKAST LEVOCITIRIZ 10 5 3X10	$50.0K	2
MSN LABS, BREATHEZY L (MONTELUKAST+ LEVO	$50.0K	1
BREATHEZY 10 MONTELUKAST 10MG 3X10	$50.0K	1

MSN Laboratories Private Limited exports 213 distinct Montelukast formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BREATHEZY L (MONTELUKAST+LEVOCITIRIZ 10+5) 3X10 with 3 shipments worth $150.0K.

How Does MSN Laboratories Private Limited Compare to Nearest Montelukast Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	CIPLA LIMITED	$4.6M	92	5	$50.0K
8	INTAS PHARMACEUTICALS LIMITED	$3.8M	400	10	$9.4K
10	MSN LABORATORIES PRIVATE LIMITED ★	$3.2M	295	18	$10.7K
11	TORRENT PHARMACEUTICALS LIMITED	$3.1M	77	13	$39.7K
9	INDOCO REMEDIES LIMITED	$3.0M	61	2	$50.0K

MSN Laboratories Private Limited ranks #10 among 510 Indian Montelukast exporters. Average shipment value of $10.7K compared to the market average of $144.3K. The closest competitors by value are CIPLA LIMITED and INTAS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Montelukast Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	537	8.4%
NHAVA SHEVA SEA (INNSA1)	528	8.2%
SAHAR AIR	479	7.4%
SAHAR AIR CARGO ACC (INBOM4)	466	7.2%
DELHI AIR	451	7.0%
JNPT/ NHAVA SHEVA SEA	286	4.4%
JNPT	224	3.5%
MUNDRA SEA	214	3.3%

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Montelukast Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.

MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Montelukast shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 295 individual customs records matching MSN Laboratories Private Limited exporting Montelukast, covering 213 formulations to 21 countries via 47 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 138+ countries, 1,324+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Montelukast

Montelukast

MSN Laboratories Private Limited — Montelukast Exporter Profile

MSN Laboratories Private Limited — Montelukast Export Profile: Buyers & Destinations

Where Does MSN Laboratories Private Limited Export Montelukast?

Who Are the Top Buyers of Montelukast from MSN Laboratories Private Limited?

What Is India's Total Montelukast Export Value and How Much Does MSN Laboratories Private Limited Contribute?

What Is the Average Shipment Value for MSN Laboratories Private Limited's Montelukast Exports?

How Does MSN Laboratories Private Limited Compare to Other Indian Montelukast Exporters?

What Montelukast Formulations Does MSN Laboratories Private Limited Export?

How Does MSN Laboratories Private Limited Compare to Nearest Montelukast Exporters?

Which Indian Ports Ship Montelukast Exports?

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Montelukast Exports

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

About MSN Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Montelukast Export Data from MSN Laboratories Private Limited

Montelukast Stats

Company Overview

Top Products by MSN Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source